BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 31677236)

  • 1. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
    García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
    J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity.
    Chamberlain K; Riyad JM; Garnett T; Kohlbrenner E; Mookerjee A; Elmastour F; Benard L; Chen J; VandenDriessche T; Chuah MK; Marian AJ; Hajjar RJ; Gurha P; Weber T
    Hum Gene Ther; 2018 Aug; 29(8):927-937. PubMed ID: 29641321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting transgene to the heart and liver with AAV9 by different promoters.
    Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
    Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
    Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.
    Prasad KM; Smith RS; Xu Y; French BA
    J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling.
    Konkalmatt PR; Beyers RJ; O'Connor DM; Xu Y; Seaman ME; French BA
    Circ Cardiovasc Imaging; 2013 May; 6(3):478-86. PubMed ID: 23536266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.
    Konkalmatt PR; Wang F; Piras BA; Xu Y; O'Connor DM; Beyers RJ; Epstein FH; Annex BH; Hossack JA; French BA
    J Gene Med; 2012; 14(9-10):609-20. PubMed ID: 23065925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.
    Prasad KM; Xu Y; Yang Z; Acton ST; French BA
    Gene Ther; 2011 Jan; 18(1):43-52. PubMed ID: 20703310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.
    Geisler A; Jungmann A; Kurreck J; Poller W; Katus HA; Vetter R; Fechner H; Müller OJ
    Gene Ther; 2011 Feb; 18(2):199-209. PubMed ID: 21048795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration.
    Chai Z; Zhang X; Rigsbee KM; Wang M; Samulski RJ; Li C
    J Control Release; 2018 Sep; 286():415-424. PubMed ID: 30107215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9.
    Chai Z; Zhang X; Dobbins AL; Rigsbee KM; Wang B; Samulski RJ; Li C
    Hum Gene Ther; 2019 Jul; 30(7):829-840. PubMed ID: 30700148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer.
    Fang H; Lai NC; Gao MH; Miyanohara A; Roth DM; Tang T; Hammond HK
    Hum Gene Ther Methods; 2012 Aug; 23(4):234-41. PubMed ID: 22966786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase.
    Werfel S; Jungmann A; Lehmann L; Ksienzyk J; Bekeredjian R; Kaya Z; Leuchs B; Nordheim A; Backs J; Engelhardt S; Katus HA; Müller OJ
    Cardiovasc Res; 2014 Oct; 104(1):15-23. PubMed ID: 25082846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes.
    Ai J; He Y; Zheng M; Wen Y; Zhang H; Huang F; Zhu Y
    Cell Physiol Biochem; 2018; 48(5):1894-1900. PubMed ID: 30092576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle.
    Pacak CA; Suzuki-Hatano S; Khadir F; Daugherty AL; Sriramvenugopal M; Gosiker BJ; Kang PB; Cade WT
    J Transl Med; 2023 Oct; 21(1):748. PubMed ID: 37875924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.
    Pleger ST; Shan C; Ksienzyk J; Bekeredjian R; Boekstegers P; Hinkel R; Schinkel S; Leuchs B; Ludwig J; Qiu G; Weber C; Raake P; Koch WJ; Katus HA; Müller OJ; Most P
    Sci Transl Med; 2011 Jul; 3(92):92ra64. PubMed ID: 21775667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained viral gene delivery from a micro-fibrous, elastomeric cardiac patch to the ischemic rat heart.
    Gu X; Matsumura Y; Tang Y; Roy S; Hoff R; Wang B; Wagner WR
    Biomaterials; 2017 Jul; 133():132-143. PubMed ID: 28433936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.